Daniel J Watford, MD
Nephrology · Seattle
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · The Association of University Physicians · 3,484 clinicians in this group
Hospitals listed: Tacoma General Allenmore Hospital · University of Washington Medical Ctr. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Watford’s office at (206) 598-4333 to ask if they take your plan before you enroll.
California Medical Board record
Licence A153704 · Delinquent
Licence status: Delinquent · since 2018 · expires 2025-07-31 · University of North Carolina at Chapel Hill.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.61261435Physician And Surgeon License · since 2022 · expires 2028-07-06ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Tacoma General Allenmore HospitalTacoma, WAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Multicare Health System, which runs 11 hospitalsPatients rate it 2 of 5 · 65% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.48, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.475, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.533, Oct 2024 – Sep 2025
- University of Washington Medical CtrSeattle, WAAcute Care Hospital · Government - State · No emergency department · Birthing-friendlyPart of UW Medicine, which runs 4 hospitalsHome of Fred Hutchinson / University of Washington / Seattle Children's Cancer Consortium, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Postoperative respiratory failure rate: 4.94 (1.58 to 8.3) · 2,791 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.48 (0.42 to 4.54) · 3,047 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.42, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.1 (6 to 10.6) · 540 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,118 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Tacoma General Allenmore Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 1 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.48 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.475 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.533 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.7 (0.85 to 2.55) · 1,883 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.19 (0.94 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 206.43 (165.02 to 247.83) · 157 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 168 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 117 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.2 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.9 · 511 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 666 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 631 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 5,025 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 8,942 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.04 to 0.4) · 9,440 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.43 (1.72 to 5.14) · 2,917 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.22 (0.85 to 3.58) · 1,368 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.42 (2.15 to 4.69) · 2,634 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.36 (7.76 to 16.96) · 1,357 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.67 (3.65 to 9.69) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.67 to 3.48) · 668 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.17 to 1.25) · 7,549 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5 · 184 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.968 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.679 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 302 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.4 · 873 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 32.2 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.5 · 574 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33.6 · 647 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 1,023 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.8 to 6.3) · 712 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.5 (9.6 to 13.6) · 712 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.2 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 146 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.5 to 16.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 942 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,937 patients answered, 19% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for University of Washington Medical Ctr
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 3 better, 7 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 4.94 (1.58 to 8.3) · 2,791 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.48 (0.42 to 4.54) · 3,047 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.42 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.1 (6 to 10.6) · 540 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,118 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.41 to 1.87) · 3,356 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.68 to 1.06) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.77 (137.68 to 205.86) · 295 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.6 · 169 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 643 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 522 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 256 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 5,179 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.14 to 0.48) · 12,916 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.14 to 0.48) · 13,941 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (2.43 to 5.19) · 5,095 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.99 (0 to 2.05) · 3,007 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.24 (2.26 to 4.23) · 4,648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.45 to 3.02) · 1,296 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.85 (0.42 to 1.28) · 11,531 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 136 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.227 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.165 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.919 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.72 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.262 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 887 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17.4 · 213 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -32.1 · 730 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 12 · 543 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 649 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.6 to 6.8) · 540 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 138 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 173 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.1 to 16.3) · 2,084 cases | No different | Jan 2022 – Dec 2024 |
What patients said (4,925 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$53,934
Medicare paid this office $53,934 for 168 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $19,855 | $100 |
| Long return visit (40+ min) | 61 | $19,481 | $112 |
| New patient visit (60+ min) | 48 | $6,647 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $3,960 | $147 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 45 | $1,941 | $14 |
Who their Medicare patients are
168 Original Medicare patients in 2024. Average age 61 · Under 65 45% · Women 43% · Also on Medicaid 28% · Health risk score 6.30. Sicker patients than 9 in 10 peers; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 61% · Coronary heart disease 38% · Heart failure 32% · Depression 27% · Atrial fibrillation 21% · Cancer 14% · Stroke 11% · COPD 10%.
The office billed $205,859, Medicare allowed $69,771 and paid $53,934; for 617 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 168 | 617 | 61 | 6.30 | $205,859 | $53,934 |
| 2023 | 160 | 646 | 59 | 6.18 | $233,608 | $71,668 |
| 2022 | 70 | 271 | 57 | 6.78 | $79,542 | $25,702 |
| 2021 | 21 | 30 | 76 | 2.34 | $20,483 | $2,945 |
| 2020 | 19 | 26 | 73 | 1.96 | $17,321 | $2,537 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 55 | $28,969 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $24,763 | $101 |
| New patient visit (60+ min) | 52 | $7,528 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,533 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,128 | $65 |
2022: 4 services
| Long return visit (40+ min) | 14 | $9,740 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $5,785 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,429 | $86 |
| New patient visit (60+ min) | 21 | $2,945 | $140 |
2020: 1 service
| New patient visit (45+ min) | 16 | $1,902 | $119 |
Medicaid work
$564 in 2023
Medicaid paid $564 for 13 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 13 | $564 |
| 2023 | 13 | 1 | 12 | $564 |
| 2022 | 56 | 2 | 18 | $1,607 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 44 | $1,023 |
| New patient visit (60+ min) | 12 | $584 |
Drugs they prescribed that Part D paid
$58,035
Pharmacies billed $58,035 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
626 generic and 48 brand-name prescriptions · $58,035 in drug cost · 81 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Valganciclovir | 36 | $5,204 | $145 |
| Ultra-Fine Mini Pen Needle | 14 | $1,206 | $86 |
| Tacrolimus | 13 | $1,105 | $85 |
| Cinacalcet | 16 | $880 | $55 |
| Prednisone | 111 | $601 | $5 |
See all 14 drugs
| Valganciclovir | 36 | $5,204 | $145 |
| Ultra-Fine Mini Pen Needle | 14 | $1,206 | $86 |
| Tacrolimus | 13 | $1,105 | $85 |
| Cinacalcet | 16 | $880 | $55 |
| Prednisone | 111 | $601 | $5 |
| Carvedilol | 55 | $472 | $9 |
| Amlodipine Besylate | 56 | $428 | $8 |
| Sulfamethoxazole-Trimethoprim | 55 | $380 | $7 |
| Atorvastatin | 48 | $299 | $6 |
| Hydralazine | 14 | $204 | $15 |
| Tamsulosin | 13 | $144 | $11 |
| Torsemide | 11 | $84 | $8 |
| Famotidine | 15 | $77 | $5 |
| Losartan | 16 | $66 | $4 |
Year by year
| 2024 | 700 | 70 | None | 7% | $58,035 |
| 2023 | 421 | 47 | None | None | $35,651 |
| 2022 | 116 | 25 | None | None | $8,229 |
| 2021 | 70 | 16 | 0% (0) | None | $3,099 |
| 2020 | 22 | None | 0% (0) | None | $360 |
| 2017 | 52 | None | 0% (0) | None | $4,435 |
| 2016 | 81 | None | 0% (0) | 33% | $16,266 |
| 2015 | 18 | None | 0% (0) | None | $7,243 |
| 2014 | 18 | None | 0% (0) | None | $1,860 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Envarsus Xr | 14 | $5,799 | $414 |
| Valganciclovir | 15 | $2,598 | $173 |
| Prednisone | 61 | $440 | $7 |
| Carvedilol | 40 | $385 | $10 |
| Amlodipine Besylate | 32 | $231 | $7 |
| Atorvastatin | 30 | $219 | $7 |
| Torsemide | 17 | $213 | $13 |
| Sulfamethoxazole-Trimethoprim | 31 | $207 | $7 |
| Famotidine | 23 | $152 | $7 |
2022: 1 drug
| Atorvastatin | 12 | $115 | $10 |
2016: 2 drugs
| Nifedipine Er | 15 | $509 | $34 |
| Famotidine | 12 | $86 | $7 |
Money from drug and device companies
$125 in 2019
A payment is not proof that care is biased.
| Amgen | Parsabiv | $125 | 1 payment
|
See the published payment
| Amgen | Meals · 2019-08-09 | Parsabiv | $125 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 93.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1992122238
- Licence
- CA A153704, WA MD61261435California A153704: Delinquent · expires 2025-07-31Washington MD.MD.61261435: Active
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 1992122238
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- Po Box 50095, Seattle, WA, 98145
- NPI first listed
- 2014-03-25
- NPI last updated
- 2022-06-14
- NPI record certified
- 2022-06-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305